Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:doxepin
|
| gptkbp:approvalYear |
2010
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
gptkb:N06AA12
|
| gptkbp:contraindication |
urinary retention
untreated narrow angle glaucoma |
| gptkbp:drugClass |
antidepressant
|
| gptkbp:form |
gptkb:tablet
|
| gptkbp:halfLife |
15 hours
|
| https://www.w3.org/2000/01/rdf-schema#label |
Silenor
|
| gptkbp:legalStatus |
Rx-only (US)
|
| gptkbp:manufacturer |
gptkb:Pernix_Therapeutics
|
| gptkbp:mechanismOfAction |
histamine H1 receptor antagonist
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
drowsiness dry mouth |
| gptkbp:usedFor |
insomnia
|
| gptkbp:bfsParent |
gptkb:doxepin
gptkb:Doxepin |
| gptkbp:bfsLayer |
7
|